Analyst Price Targets — NEOG
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| September 30, 2026 10:53 am | — | Guggenheim | $14.00 | $12.73 | TheFly | Neogen price target raised to $14 from $12 at Guggenheim |
| August 3, 2026 11:33 am | — | Piper Sandler | $13.00 | $12.04 | TheFly | Neogen price target raised to $13 from $11 at Piper Sandler |
| January 12, 2026 12:05 pm | David Westenberg | Piper Sandler | $10.00 | $9.27 | TheFly | Neogen price target raised to $10 from $6.50 at Piper Sandler |
| January 9, 2026 11:55 am | — | Guggenheim | $12.00 | $9.71 | TheFly | Neogen price target raised to $12 from $8 at Guggenheim |
| October 16, 2025 10:49 am | David Westenberg | Piper Sandler | $6.50 | $5.95 | TheFly | Neogen price target raised to $6.50 from $5 at Piper Sandler |
| April 22, 2025 11:06 am | David Westenberg | Piper Sandler | $5.00 | $4.75 | TheFly | Neogen price target lowered to $5 from $6.40 at Piper Sandler |
| August 6, 2024 7:21 am | David Westenberg | Piper Sandler | $17.50 | $16.15 | TheFly | Neogen price target raised to $17.50 from $17 at Piper Sandler |
| December 14, 2022 6:34 pm | David Westenberg | Piper Sandler | $17.00 | $15.35 | TheFly | Neogen price target raised to $17 from $14 at Piper Sandler |
| October 9, 2022 8:57 pm | David Westenberg | Piper Sandler | $14.00 | $12.68 | TheFly | Neogen price target lowered to $14 from $20 at Piper Sandler |
Latest News for NEOG
NEW YORK, Oct. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Neogen Corporation ("Neogen" or the "Company") (NASDAQ: NEOG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
NEW YORK, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Neogen Corporation (“Neogen” or the “Company”) (NASDAQ: NEOG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Neogen beats Where Food Comes From in revenue growth and recovery potential, but higher debt and integration risks complicate the food safety stock showdown.
LOS ANGELES, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Neogen Corporation (“Neogen” or the “Company”) (NASDAQ: NEOG) investors concerning the Company's possible violations of the federal securities laws.
NEW YORK, Oct. 15, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Neogen Corporation ("Neogen" or the "Company") (NASDAQ: NEOG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for NEOG.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.